Previous 10 |
Even as we see US rates making an orderly retracement away from record lows, we are struck by the angst this is causing many investors. In our view, rising interest rates should not of themselves be a cause for alarm. For equity investors, and especially those investing in value secto...
Last week, the latest US fiscal stimulus was signed into law, delivering $1.9 trillion of aid to a wide range of people and groups, as well as other non-COVID related spending. We know from the prior two COVID aid bills that direct aid can make a substantial economic impact. While...
By Avi Lavi and James MacGregor The coronavirus crisis and recession have pummeled value stocks as investors shun riskier parts of the market. Yet these conditions have left some higher-quality companies trading at valuations that underestimate their ability to withstand shorter-term str...
By Philip Lawlor, managing director, head of Global Markets Research US stocks regained their dominance with the global risk rally of the past two months, and US small caps have led the way. The Russell 2000 is up almost 40% from its March 23 low, outstripping the gains of 38% the Russell ...
Sign up for Let's Talk ETFs on the podcast platform of your choice to make sure you don't miss an episode: Apple Podcasts Spotify Google Play Stitcher By Jonathan Liss Growth stocks have been on a historic tear over the last decade and change - outperforming ...
By Jonathan Liss The spark for today's conversation was an article that my guest, Victor Haghani , posted to Seeking Alpha back on July 18 of this year titled Smart Beta: The Good, The Bad, And The Muddy . In it Victor helped crystallize some of the issues I myself have been s...
Dr. David Kelly and his team at JPMorgan put together - each quarter - one of the best capital market, economic and portfolio management summaries on the Street in the form of JPMorgan's "Guide to the Market". This valuation table is typically found in the first 10 pages of "The Guide". Here...
By Ansh Chaudhary For the month of May, the ETF Deathwatch increased in size. Twenty-nine exchange-traded products ("ETPs") were added to the list, and 19 funds were removed, making May a busier month in terms of additions. Of the removals, 16 were removed due to increased health and three...
By Ansh Chaudhary For the month of March, the ETF Deathwatch increased in size. Twenty-four exchange-traded products ("ETPs") were added to the list, and 18 funds were removed. Of the removals, eight were removed due to improved health and 10 were due to asset managers closing their funds....